Panuveitis Clinical Trial
Official title:
Phase 3 Confirmatory Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Anterior Uveitis (Including Panuveitis).
The purpose of this phase 3 confirmatory study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of treatment of uveitis.
The objective of this phase 3 study is to assess the efficacy and safety of 0.05% difluprednate ophthalmic emulsion (DFBA) in patients with endogenous anterior uveitis, in comparison with 0.1% betamethasone sodium phosphate ophthalmic solution (BP). ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01280669 -
Intravitreal Sirolimus as Therapeutic Approach to Uveitis
|
Phase 2 | |
Terminated |
NCT03656692 -
Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)
|
Phase 4 | |
Completed |
NCT02255032 -
Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
|
Phase 2 | |
Recruiting |
NCT05101928 -
Ozurdex Monotherapy Trial
|
Phase 4 | |
Completed |
NCT00167583 -
Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)
|
Phase 3 | |
Completed |
NCT02595398 -
Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis
|
Phase 3 | |
Recruiting |
NCT00407316 -
Quality of Life and Visual Function in Uveitis Patients
|
Phase 0 | |
Completed |
NCT02746991 -
Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis
|
Phase 3 | |
Recruiting |
NCT06085079 -
Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study
|
Phase 4 | |
Completed |
NCT02725177 -
Ocular Sarcoidosis Open Label Trial of ACTHAR Gel
|
N/A | |
Completed |
NCT00908466 -
Sirolimus as Therapeutic Approach to Uveitis
|
Phase 1 | |
Completed |
NCT00615693 -
Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis
|
Phase 2 | |
Completed |
NCT00404742 -
A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis
|
Phase 3 | |
Completed |
NCT00404885 -
A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis
|
Phase 3 | |
Completed |
NCT00404612 -
A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis
|
Phase 3 | |
Completed |
NCT01789320 -
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
|
Phase 1/Phase 2 | |
Completed |
NCT02952001 -
MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
|
||
Completed |
NCT00407056 -
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis
|
Phase 3 | |
Completed |
NCT03097315 -
Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis
|
Phase 3 |